Disc Medicine Inc [IRON] stock prices are up 20.95% to $89.94 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The IRON shares have gain 28.67% over the last week, with a monthly amount glided 43.61%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Disc Medicine Inc [NASDAQ: IRON] stock has seen the most recent analyst activity on July 21, 2025, when Truist initiated its Buy rating and assigned the stock a price target of $86. TD Cowen started tracking the stock assigning a Buy rating. Morgan Stanley upgraded its rating to a Overweight but $85 remained the price target by the analyst firm on November 05, 2024. Raymond James upgraded its rating to Strong Buy for this stock on November 04, 2024, and upped its price target to $110. In a note dated October 23, 2024, Jefferies initiated an Buy rating and provided a target price of $89 on this stock.
The stock price of Disc Medicine Inc [IRON] has been fluctuating between $30.82 and $78.17 over the past year. Currently, Wall Street analysts expect the stock to reach $123.67 within the next 12 months. Disc Medicine Inc [NASDAQ: IRON] shares were valued at $89.94 at the most recent close of the market. An investor can expect a potential return of 37.5% based on the average IRON price forecast.
Analyzing the IRON fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.22, Equity is -0.27 and Total Capital is -0.26. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.05.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 83.90 points at the first support level, and at 77.85 for the second support level. However, for the 1st resistance point, the stock is sitting at 95.97, and for the 2nd resistance point, it is at 101.99.
Ratios To Look Out For
It’s worth pointing out that Disc Medicine Inc [NASDAQ:IRON]’s Current Ratio is 32.11. On the other hand, the Quick Ratio is 32.11, and the Cash Ratio is 6.18.
Transactions by insiders
Recent insider trading involved Atlas Venture Opportunity Fund, Shareholder, that happened on Oct 17 ’25 when 35000.0 shares were purchased. Shareholder, Atlas Venture Opportunity Fund completed a deal on Oct 17 ’25 to buy 35000.0 shares. Meanwhile, Shareholder Atlas Venture Fund X, LP bought 50000.0 shares on Oct 17 ’25.
